Search the Newsreel

Will Surging Half-Year Profitability Change G Mining Ventures' (TSX:GMIN) Investment Narrative?

Biohaven Ltd. $BHVN Shares Bought by Quantinno Capital Management LP

Quantinno Capital Management LP significantly increased its stake in Biohaven Ltd. (BHVN) by 190% in the first quarter, bringing its total to 121,554 shares. Several other institutional investors also expanded their positions, contributing to the high institutional ownership of 88.78%. Despite a reported quarterly …

SCS Capital Management LLC Makes New Investment in Ventas, Inc. $VTR

SCS Capital Management LLC has made a new investment in Ventas, Inc. (NYSE:VTR), acquiring 298,587 shares valued at approximately $26.65 million. This move positions SCS Capital Management with a 0.06% stake in the healthcare REIT, which is largely owned by institutional investors (94.18%). Analysts …

Is Driven Brands Holdings (DRVN) Undervalued After Rejecting A $18 Per Share Offer?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Activist pressure puts Driven Brands Holdings (DRVN) under the spotlight Driven Brands Holdings (DRVN) is back in focus after ADW Capital Management publicly …

ArriVent BioPharma (AVBP) Could Be 56% Undervalued After The Allist China Licensing Deal

110,040 Shares in Ventas, Inc. $VTR Bought by ABN AMRO Bank N.V.

ABN AMRO Bank N.V. recently acquired 110,040 shares of Ventas, Inc. (NYSE:VTR) valued at approximately $9.79 million during the second quarter. Other institutional investors like Deutsche Bank AG, Bank of New York Mellon Corp, and Norges Bank also increased their stakes or bought new …

How (SOLV) Movements Inform Risk Allocation Models

This article analyzes Solventum Corporation (NASDAQ: SOLV) using AI models to provide trading strategies and risk allocation insights. Key findings indicate a breakout underway with compelling upside potential due to strong near and mid-term sentiment, and no resistance levels above the current price. Three …

Biohaven (BHVN) Could Be 73% Undervalued As Regeneron Deal Expands

Biohaven (BHVN) has expanded its oncology collaboration with Regeneron Pharmaceuticals, leading to recent stock momentum despite a longer history of weak returns and losses. Simply Wall St's Discounted Cash Flow (DCF) model estimates BHVN to be 73% undervalued with a fair value of $54.53 …

Ventas (VTR) Stock Looks Reasonable Even With Mixed Value Signals

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Ventas stock has more than doubled over the past three years, yet its valuation …

Technical Reactions to AVBP Trends in Macro Strategies

This article provides a technical analysis of Arrivent Biopharma Inc. (NASDAQ: AVBP) trends, highlighting neutral near and mid-term readings but a potentially strong long-term positive bias. It details institutional trading strategies, including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The …

Crest Ventures Q1 Results: Net profit drops 84% YoY to ₹3.5 crore

Fischer Medical Ventures consolidated net profit declines 22.02% in the June 2026 quarter

Venture Global Inc (VG) News, Articles, Events & Latest Updates

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Enliven Therapeutics (NASDAQ:ELVN) has received a "Moderate Buy" consensus rating from brokerages, with an average 12-month price target of $72.67. This comes despite the company reporting a wider-than-expected quarterly loss of $0.49 per share. Recent insider selling, including a director's $9.6 million sale, has …

G Mining Ventures (TSX:GMIN) Could Be 18% Undervalued After Strong Q2 Results

EVEN3 - Even - Resultados, Dividendos, Cotação e Indicadores

PIMCO reports 32.4% Venture Global (VG) Class A stake with 0.9% voting power

PIMCO has reported a beneficial ownership of 172,261,658 Class A Common Stock shares in Venture Global, representing 32.4% of the outstanding Class A shares. Despite this significant Class A ownership, PIMCO's total combined voting power in Venture Global is approximately 0.9% due to the …

Innventure (NASDAQ:INV) Downgraded to Sell Rating by Wall Street Zen

Innventure (NASDAQ:INV) has been downgraded to a "sell" rating by Wall Street Zen, adding to existing "sell" recommendations and a consensus target price of $5.00 from MarketBeat. This downgrade follows the company's significant Q2 loss of $0.32 per share, missed revenue estimates, and widening …

CEO EVENT MEDYA (CEOEM) Hisse Senedi

VG Stock Surges On New LNG Supply Deals, Strong Q1 Report – Retail Says Venture Global Is A Solid Hold

Venture global SVP Sarah Blake sells $14 million in stock

Sarah Blake, SVP and Chief Accounting Officer at Venture Global, sold 1,000,000 shares of Class A Common Stock for $14,023,200 on August 14, 2026, following the exercise of stock options. This sale occurred as VG stock rose 50% in six months and despite the …

Sarah Blake, SVP de Venture Global, vende acciones por 14 millones de dólares

SOLV Energy (MWH) Stock Faces Margin Questions Despite Raised Guidance

Covenant Logistics (CVLG): Buy, Sell, or Hold Post Q2 Earnings?

Covenant Logistics (CVLG): Buy, Sell, or Hold Post Q2 Earnings? Since August 2021, the S&P 500 has delivered a total return of 73.7%. But one standout stock has more than doubled the market - over the past five years, Covenant Logistics has surged 201% …

Seven Hills Realty Trust (SEVN) Q2 2026 Earnings Report - Results, Call & Slides

Is Biohaven’s Narrowing Losses and AI Board Hire Altering The Investment Case For Biohaven (BHVN)?

Biohaven Ltd. reported narrowing losses in Q2 2026, with a net loss of US$137.31 million, and appointed AI-focused investor John Yetimoglu to its Board. Despite these developments, the company still faces significant financial risk due to zero revenue, heavy ongoing losses, and a short …

Is Biohaven (BHVN)’s Latest Regeneron Pharmaceuticals (REGN) Deal a Major Catalyst for its Pipeline?

Two prominent biopharmaceutical names, Biohaven Ltd. (NYSE:BHVN) and Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), are deepening their relationship across oncology. On July 20, Biohaven announced a clinical supply agreement with Regeneron to evaluate the combination of BHV-1530 and Regeneron's cemiplimab (Libtayo) in patients with solid tumors. …

Perceptive Advisors (NVNO) reports 3.5% beneficial stake via 24,605 warrants

Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have reported a beneficial ownership of 3.5% in enVVeno Medical Corporation (NVNO) through 24,605 exercisable warrants. This stake represents 24,605 shares of common stock, based on 682,722 shares outstanding as of July …

Insider Selling: Venture Global (NYSE:VG) Director Sells $881,100.00 in Stock

Venture Global (NYSE:VG) CAO Sells $14,020,000.00 in Stock

Form 8K Covenant Logistics Group Inc For: 14 August By Investing.com

This article from Investing.com announces the filing of a Form 8K by Covenant Logistics Group Inc. on August 14th. The brief piece includes the stock symbol CVLG and mentions a slight positive change in its value. The content primarily serves as a notification of …

Venture Global (VG) director exercises 200,000 options and sells 200,000 shares

Venture Global, Inc. director Granat Sari Beth reported an options exercise and sale sequence on August 13, 2026. She exercised 200,000 stock options at an exercise price of $2.66 per share and subsequently sold 200,000 shares of Class A Common Stock at a weighted …

Venture global director Jimmy Staton sells $881k in stock

Venture Global director Jimmy D. Staton sold 66,000 shares of Class A Common Stock for $881,034 after acquiring 1,100,000 shares through stock options on the same day. Following these transactions, Staton directly holds 1,083,000 shares and 1,160,165 stock options. The company, valued at $34.8 …